Sadeek Sidney Kanoun Schnur

Dr. Sadeek Sidney Kanoun Schnur

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Trends in Cardiovascular Medicine
Verified
Journal Article
Closed access
SSSadeek Sidney Kanoun Schnur
Sadeek Sidney Kanoun Schnur
Alexandru AchimAlexandru Achim
Alexandru Achim
GTGabor G Toth
Gabor G Toth

1 March 2019 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
GFGuy O. Furniss
Guy O. Furniss
DPDimitrios Panagopoulos
Dimitrios Panagopoulos
SSSadeek Sidney Kanoun Schnur
Sadeek Sidney Kanoun Schnur
EDEdward J. Davies
Edward J. Davies
DTDavid R. Tomlinson
David R. Tomlinson
GHGuy A. Haywood
Guy A. Haywood

Verified
Journal Article
Open access
PDF file
DPDan Mihai Prunea
Dan Mihai Prunea
EBEva Bachl
Eva Bachl
LHLukas Herold
Lukas Herold
SSSadeek Sidney Kanoun Schnur
Sadeek Sidney Kanoun Schnur
SPSascha Pätzold
Sascha Pätzold
Toth-Gayor GaborToth-Gayor Gabor
Toth-Gayor Gabor
(1) Background: Mechanical circulatory support (MCS) in myocardial infarction-associated cardiogenic shock is subject to debate. This analysis aims to elucidate the impact of MCS’s timing on patient outcomes, based on data from the PREPARE CS registry. (2) Methods: The PREPARE CS prospective registry includes patients who experienced cardiogenic shock (SCAI classes C–E) and were subsequently referred for cardiac catheterization. Our present analysis included a subset of this registry, in whom MCS was used and who underwent coronary intervention due to myocardial infarction. Patients were categorized into an Upfront group and a Procedural group, depending on the timing of MCS’s introduction in relation to their PCI. The endpoint was in-hospital mortality. (3) Results: In total, 71 patients were included. MCS was begun prior to PCI in 33 (46%) patients (Upfront), whereas 38 (54%) received MCS during or after the initiation of PCI (Procedural). The groups’ baseline characteristics and hemodynamic parameters were comparable. The Upfront group had a higher utilization of the Impella® device compared to extracorporeal membrane oxygenation (67% vs. 33%), while the Procedural group exhibited a balanced use of both (50% vs. 50%). Most patients suffered from multi-vessel disease in both groups (82% vs. 84%, respectively; p = 0.99), and most patients required a complex PCI procedure; the latter was more prevalent in the Upfront group (94% vs. 71%, respectively; p = 0.02). Their rates of complete revascularization were comparable (52% vs. 34%, respectively; p = 0.16). Procedural CPR was significantly more frequent in the Procedural group (45% vs. 79%, p < 0.05); however, in-hospital mortality was similar (61% vs. 79%, respectively; p = 0.12). (4) Conclusions: The upfront implantation of MCS in myocardial infarction-associated CS did not provide an in-hospital survival benefit.

2 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FLFriederike von Lewinski
Friederike von Lewinski
Franz QuehenbergerFranz Quehenberger
Franz Quehenberger
MSMichael Sacherer
Michael Sacherer
VTValentin Taucher
Valentin Taucher
CSChristoph Strohhofer
Christoph Strohhofer
DLDirk Von Lewinski
Dirk Von Lewinski
Background/Objectives: Ambient air pollution is a significant public health concern, known to affect cardiovascular health adversely. Research has identified both long-term and short-term cardiovascular risks associated with various air pollutants, including those linked to acute coronary syndromes. However, the observed effects are rather small, with most data sourced from highly polluted regions. Methods: This study utilized a prospective registry database, documenting 12,581 myocardial infarction (MI) events in Styria, Austria from January 2007 to December 2015. Pollutants analyzed included particulate matter (PM2.5, PM10) and gases, such as NO2, CO, SO2, O3 and NOx. We employed generalized linear models to examine the interaction of each of these pollutants on the daily incidence of MI. Additionally, we conducted separate analyses for patients with specific comorbidities: diabetes mellitus (DM), arterial hypertension (HTN), heart failure with reduced ejection fraction (HFrEF), chronic obstructive pulmonary disease (COPD) and current smokers. Results: No significant associations were identified between any of the pollutants and MI incidence, both in the overall cohort and in patient subgroups with DM, HTN, HFrEF or COPD. However, among active smokers, we observed a decreased relative risk of MI associated with elevated levels of NO2, CO, SO2 and NOx on the day of MI (p < 0.01 for all pollutants). Conversely, an increased MI risk was associated with rising ozone levels (p = 0.0027). This counterintuitive finding aligns with previously published data and may suggest a new dimension to the “smoker’s paradox”. Conclusions: In regions with low pollution levels, air pollutants pose only minor or insignificant short-term risks for myocardial infarction. Active smokers exhibit an altered response to ambient air pollution.

28 October 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Open access
SSSadeek Sidney Kanoun Schnur
Sadeek Sidney Kanoun Schnur
SDSen Devadathan
Sen Devadathan
RMRyan Moran
Ryan Moran
SHStefan Harb
Stefan Harb
Toth-Gayor GaborToth-Gayor Gabor
Toth-Gayor Gabor
Zoltán RuzsaZoltán Ruzsa
Zoltán Ruzsa

11 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
DPDan Mihai Prunea
Dan Mihai Prunea
EBEva Bachl
Eva Bachl
LHLukas Herold
Lukas Herold
SSSadeek Sidney Kanoun Schnur
Sadeek Sidney Kanoun Schnur
SPSascha Pätzold
Sascha Pätzold
Toth-Gayor GaborToth-Gayor Gabor
Toth-Gayor Gabor
(1) Background: Mechanical circulatory support (MCS) in myocardial infarction associated cardiogenic shock is subject to debate. This analysis aims to elucidate the impact of MCS timing on patient outcomes, based on data from the PREPARE CS registry.; (2) Methods: PREPARE CS prospective registry included consecutive patients experiencing cardiogenic shock (SCAI Classes C-E) and were referred for cardiac catheterization. Present analysis included a subset, in whom MCS was used and underwent coronary intervention due to myocardial infarction. Patients were categorized into Upfront group versus Procedural group, depending on the timing of MCS introduction in relation to PCI. Endpoint was the in-hospital mortality; (3) Results: In total 71 patients were included. MCS was started prior to PCI in 33 (46%) patients (Upfront), whereas 38 (54%) received MCS during or after PCI initiation (Procedural). Baseline characteristics and hemodynamic parameters were comparable. The Upfront group had a higher utilization of Impella® device compared to extracorporeal membrane oxygenation (67% vs 33%), while the Procedural group exhibited a balanced use (50% vs 50%). Most patients suffered of multi-vessel disease in both groups (82% vs 84%, respectively; p=0.99) and most patients required complex PCI procedure, the latter was more prevalent in the Upfront group (94% vs 71%, respectively; p=0.02). Rates of complete revascularization were comparable (52% vs 34%, respectively; p=0.16). Procedural CPR was significantly more frequent in the Procedural group (45% vs 79%, p<0.05), still in-hospital mortality was similar (61% vs 79%, respectively; p=0.12); (4) Conclusions: Upfront implantation of MCS in myocardial infarction associated CS did not provide in-hospital survival benefit.